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An in vitro approach was used to measure the genotoxicity of creosote-contaminated soil before
and after four bioremediation processes. The soil was taken from the Reilly Tar site, a closed
Superfund site in Saint Louis Park, Minnesota. The creosote soil was bioremediated in bioslurry,
biopile, compost, and land treatment, which were optimized for effective treatment. Mutagenicity
profiles of dichloromethane extracts of the five soils were determined in the Spiral technique of
the Salmonella assay with seven tester strains. Quantitative mutagenic responses in the plate
incorporation technique were then determined in the most sensitive strains, YG1041 and
YG1042. Mutagenic potency (revertants per microgram extract) in YG1041 suggested that
compost, land treatment, and untreated creosote soil extracts were moderately mutagenic with
Arochlor-induced rat liver (S9) but were nonmutagenic without S9. However, the bioslurry extract
was strongly mutagenic and the biopile extract was moderately mutagenic either with or without
S9. A similar trend was obtained in strain YG1042. The strong mutagenic activity in the bioslurry
extract was reduced by 50% in TA98NR, which suggested the presence of mutagenic
nitrohydrocarbons. Variation in reproducibility was 15% or less for the bioassay and extraction
procedures. Bioavailability of mutagens in the biopile soil was determined with six solvents;
water-soluble mutagens accounted for 40% of the total mutagenic activity and they were stable
at room temperature. The mutagenic activity in the bioslurry and biopile samples was due to
either the processes themselves or to the added sludge/manure amendments. The in vitro
approach was effective in monitoring bioremediated soils for genotoxicity and will be useful in
future laboratory and in situ studies. Environ Health Perspect 106(Suppl 6):1427-1433 (1998).
http.//ehpnetl.niehs.nih.gov/docs/1998/Suppl-6/1427-1433hughes/abstract.html
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Coal tar creosote consists mainly (80-85%)
ofpolycyclic aromatic hydrocarbons (PAHs)
(1); therefore, creosote generally requires
metabolic activation to show mutagenic
activity (2-6). Creosote contains carcino-
gens (7,8) and causes DNA adducts in
mouse skin (9) and tumors in fish (10,11).
Creosote is an animal carcinogen and there
is limited evidence for carcinogenicity in
humans (12). Because it has been used as a
wood preservative since the early 1900s,
approximately 415 Superfund sites have soil
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and groundwater contaminated with
creosote (1,13-17). There are many
methods available to remediate a hazardous
waste site soil (18-22). The presumptive
treatments for soils, sediments, and sludge
contaminated with organics at wood treat-
ment sites are bioremediation, thermal des-
orption, and incineration (19).
Bioremediation is a cost-effective
process to degrade wastes, and techniques
are reviewed elsewhere (23-26). Biore-
mediation takes advantage ofthe ability of
bacteria (27-30), fungi (31,32), and
plants (33) to degrade many toxicants.
Indigenous bacteria and fungi often uti-
lize organic toxicants as sources of carbon
and energy (34,35) and can be aug-
mented with nutrients in situ or isolated
and propagated outside the laboratory for
use with specific hazardous soils (22,36,
37). Biosurfactants increase the solubility
ofthe toxicants, which releases them from
soil particles so that bacteria and fungi
can more easily metabolize them (38-40),
but increased water solubility can lead to
water contamination.
This research investigated the
genotoxicity ofcreosote-contaminated soil
from a closed Superfund site, the Reilly Tar
site (RTS) in St. Louis Park, Minnesota,
before and after bioremediation in four lab-
oratory-scale processes: bioslurry (BS),
biopile (BP), compost (CMP), and land
treatment (LT). Mutagenic activity was
measured in two Salmonella assay tech-
niques (41,42). Reproducibility of the
mutagenicity assay and the extraction
scheme was determined, and the bioavail-
ability of the mutagens in the BP soil was
investigated. Chemical fractionation and
identification ofsignature mutagens in the
RTS soils are presented in a companion
paper (43).
Materials and Methods
Chemicals
The dichloromethane (DCM) used for the
extraction of organics from the RTS soils
and as a solvent for the Spiral mutagenicity
assay (42) was gas chromatography grade,
and the dimethyl sulfoxide (DMSO) used
as a solvent for the plate incorporation
mutagenicity bioassay (41) was a spec-
trophotometric grade. Both DCM and
DMSO were obtained from Burdick and
Jackson (Muskegon, Michigan). The water
used for the bioavailability experiment was
deionized-distilled, sterilized municipal
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water from Durham, North Carolina,
prepared at the U.S. Environmental
Protection Agency (Research Triangle Park,
North Carolina). The artificial seawater
(saltwater) was obtained from Aquarium
Systems (Mentor, Ohio). The Corexit 9527
is a commercial oil dispersant and was
obtained from Shell Oil Company (Dallas,
Texas). Toluene used for the bioavailability
experiment was a spectrophotometric grade
from Burdick and Jackson. The positive
controls for the direct-acting (-S9) condi-
tions were 2-nitrofluorene (TA98,
YG1041), sodium azide (TA100, YG1042),
methylmethane sulfonate (TA104), mito-
mycin C (TA102), and 9-aminoacridine
(TA97). The positive controls for the mam-
malian liver activation (+S9) conditions
were: 2-aminoanthracene (TA97, TA98,
TA100, YG1041, YG1042, TA104) and
danthron (TA102). All control chemicals
were obtained from the Sigma Chemical
Company (St. Louis, Missouri).
ReillyTarSiteSoils
Untreated Creosote-Contaminated Soil
from the Reilly Tar Site. The untreated
creosote-contaminated soil (UTS) was
obtained from a former Superfund site
that was a creosote (coal tar) wood treat-
ment facility in operation from 1917 to
1972. The UTS, which had a maximum
concentration of 3000 mg PAH/kg dry
soil, extended to a depth of 80 ft and was
a sandy loam soil. A composite UTS sam-
ple was created by mixing twenty-two 55-
gal drums of soil and passing the soil
through a vibrating screen to remove large
rocks and debris. Each process used a dif-
ferent size ofscreened soil, from less than
1 inch to less than 1/4 inch. The UTS
was collected in the spring of 1996 and
was kept at 4°C until it was extracted for
mutagenicity testing in January 1997.
The UTS was the starting soil for all four
bioremediation processes.
Bioslu-ry. The BS mixture used UTS of
less than 1/4-inch particle size. Treatment
was performed in stirred (500 rpm) glass
laboratory reactors (8-liter capacities) and air
was bubbled to the bottom ofthe reactors.
Ports were provided at the top ofthe reactor
for periodic addition ofnutrients, slurry, or
air. The soil slurry was amended to keep the
carbon:nitrogen:phosphorus ratio at
100:10:1, and an Organisation for Eco-
nomic Co-operation and Development
(OECD) nutrient mixture was added that
contained trace minerals and vitamins (44).
The BS soil samples for the mutagenicity
assays were a composite sample from three
separate BS treatments. A 1% activated
sludge from a municipal wastewater treat-
ment facility was used for one ofthe treat-
ments to increase the bacterial diversity.
Detailed descriptions of the bioslurry
treatments are available (45). BS soil sam-
ples for mutagenicity assays were taken
after 41 days ofoperation.
Biopile. The BP process used UTS
screened to less than 1-inch particle size.
The BP reactor was a rectangular polyethyl-
ene tank that contained 2 cubic yards of
soil with two humidified air ports (0.5
liter/min, equal to one complete air
change/24 hr). Cow manure was added to
the reactor at 1%, and nutrients were added
to keep a constant ratio of 100:10:1 for
carbon: nitrogen:phosphorus. The reactor
was sealed during the course of this study.
The BP sample for the mutagenicity studies
was taken at 20 weeks from the middle of
the BP reactor, which contained 5% fungi
by weight from oyster mushrooms
(Pleurotus ostrates).
Compost. The CMP process used UTS
screened to less than 1/2-inch particle size.
The CMP reactors consisted of 55-gal
stainless steel inner drums that were
welded, sealed, and insulated within 95-gal
outer drums that prevented heat loss dur-
ing the composting process. Details for the
CMP treatment are available (46). The
composters were placed on a conveyor belt
every day and rolled for 30 min. Samples
of CMP for mutagenicity testing were
taken at 12 weeks ofoperation.
Land Treatment. The LT process used
UTS screened to less than 1/2-inch particle
size. The LT reactors are described in detail
elsewhere (47,48). In brief, an LT reactor
consisted of a stainless steel pan containing
about 30 kg ofdry soil (1.5 cubic feet of
soil). Soil was placed in the pan to a depth
of 8 inches, which was characteristic of
field-scale LT. Four ofthese pans were sus-
pended in a water bath and housed in a
custom-built Plexiglas and steel glove box
(47). Air entered the box through a high-
efficiency particulate air filter and was
vented through a ventilation duct. Six glove
boxes held the 24 pans used in this study.
The soil was aerated through weekly tilling
by hand with a pitchfork. The temperature
was controlled at 200C (± 3°C). Soil mois-
ture was maintained in the range of 12 to
14% (moisture mass relative to wet soil) by
weekly moisture measurements and corre-
sponding weekly additions of a calculated
amount of distilled water. Soil pH was
monitored at 0, 8, 16, and 25 weeks, but
no effort was made to control the soil pH.
Soil pH varied little, ranging from 8.04 to
8.41. The LT sample for this study was a
composite sample from six of these reac-
tors to which no amendments were added.
Samples for mutagenicity testing were
taken after 25 weeks ofoperation.
Dichloromethane Extraction Procedure
to Remove the Organic Fractionfrom the
Reilly Tar Site Soilsfor Mutagenicity
Testing. Dichloromethane (200 ml) was
added to 100 g ofeach ofthe five soil types
(UTS, BS, BP, CMP, and LT) taken at the
end ofeach process. The UTS was used as
the starting soil for each process and there-
fore was the control soil at time zero. The
soil/DCM mixture was sonicated for 15
min; this procedure was performed three
times. The DCM was siphoned from the
extracted soil, combined, dried with
sodium sulfate and filtered through a 0.45
g Teflon filter (Millipore Corporation,
Marlborough, Massachusetts). The DCM
extract was concentrated under a stream of
gaseous nitrogen to 25 ml. Soils were ini-
tially concentrated to 10 mg organics per
milliliter DCM for Spiral technique testing.
The DCM extract was solvent-exchanged
into DMSO and filter-sterilized (0.45 p
Millipore filters) before it was tested for
mutagenic activity in the plate incorpora-
tion assay. The DCM was taken through
these same procedures and was used as a
procedural control (i.e., lab solvent blank in
DCM [LRB]).
MutagenicityProdures
Spiral Technique. The Spiral technique
(42) was used on the DCM soil extracts
(10 mg organics per milliliter DCM) to
determine which samples were mutagenic
and which specific strain and activation
conditions were most appropriate for sub-
sequent studies. The Salmonella strains
used in the Spiral testing were TA97,
TA98, TA100, TA102, TA104, YG1041,
and YG1042 (41,49). The TA strains were
obtained from B. Ames (University of
California, Berkeley, California); the YG
strains were obtained from T. Nohmi
(National Institute of Hygienic Sciences,
Tokyo, Japan). The Aroclor-induced (500
mg Aroclor 1254 per kilogram rat body
weight) rat liver 9000xgsupernatant (S9)
was obtained from Organon Teknika
Corporation (Durham, North Carolina)
and was stored at -80°C. The protein con-
centration of the S9 was 45.3 mg protein
per milliliter. The colonies were counted
on a Spiral laser counter using the SALS
program (42), which transformed the
Spiral data to an equivalent number of
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revertants at each specific dose level for a
100-mm petri dish. The Spiral plater and
counter were obtained from Spiral System
Instruments, Inc. (Cincinnati, Ohio).
Plate Incorporation Technique. The
plate incorporation technique was
conducted as described by Maron and
Ames (41), except that the base agar layer
contained the trace amounts ofhistidine
and biotin necessary for initial replication,
and the plates were incubated for 72 hr
(50). Based on the Spiral results, soil sam-
ples were tested with strains YG1041 and
YG1042 with and without S9 at 10 doses,
triplicate plates per dose. The exogenous
activation system was from Aroclor-
induced rat liver S9, and 500 pl ofa 6% S9
mixture was added to each plate.
Mutagenic potencies (revertants per micro-
gram) were determined by the Bernstein
linear regression rejection model, which
rejects nonlinear data from the upper por-
tion of the dose-response curve. The
Bernstein model does not adjust for toxic-
ity, requires three acceptable dose levels,
and therefore provides very conservative
mutagenic potencies (51,52). Statistical
models that adjust for toxicity and include
all data in their calculations [e.g., Stead
model (53)] have higher mutagenic poten-
cies. The GeneTox Manager statistical
analysis program (54) was used to record
the data and generate the Bernstein
mutagenic potencies (55).
Nitroreductase Study. Nitroreductase-
deficient strain TA98NR was obtained
from H. Rosenkranz (University of
Pittsburgh, Pittsburgh, Pennsylvania). The
methods for the nitroreductase strains are
contained in Rosenkranz and Poirier (56).
Reproducibility Studies. Experiments
were performed to evaluate the repro-
ducibility of the extraction and bioassay
techniques over time. Reproducibility was
measured as percent coefficient ofvariation
(CV) in the mutagenic activity of BP
extracts over time. Variation below 25%
was considered acceptable. Three separate
BP samples were extracted by DCM on the
same day and solvent-exchanged in DMSO
for mutagenicity testing. Bioassay parame-
ters were as follows: strain YG1041, with-
out S9, and 10 dose levels (10-100 pg/plate
in intervals of 10 pg), with triplicate plates
per dose. Three experiments were con-
ducted on these three BP extracts on three
separate days; experiments were spaced one
week apart.
Bioavailability Study. The following
six solvents (200 ml each) were added to
100 g UTS and BP soil to measure the
mutagenic activity that could be extracted
(i.e., the bioavailability of mutagens) by
each solvent: Corexit 9527 (a widely used
dispersant) at a dilution of 1:1000 in
water; sterile water; artificial seawater; a
mixture of 50% water and 50% artificial
seawater (50:50); toluene; and DCM. The
soil/extract mixtures were shaken in glass
jars for 2 min then centrifuged for 20 min
at 6000 rpm. The supernatants were
decanted and 200 ml DCM was added to
each of the supernatants. This mixture
was then shaken for 2 min and the
organic phase was removed. This proce-
dure was repeated a total of three times.
The three organic phases were combined,
filtered through a Millipore filter (0.45 g)
overlaid with 1 to 2 cm sodium sulfate to
dry the extract, and concentrated to 25 ml
in a rotoevaporation apparatus. A muta-
genicity assay was performed on each
extract with YG1041, no S9 addition, five
dose levels (100, 75, 50, 25, and 10
pg/plate), triplicate plates per dose. The
three waters were used to simulate various
aquatic environments contaminated by
various PAH-containing pollutants, the
Corexit 9527 was utilized as a positive
control dispersant, the toluene was used
to simulate a potential solvent front com-
monly seen moving away from a creosote
point source, and DCM was tested as the
standard extraction solvent. The DMSO
was the bioassay solvent control.
Results
MutagenicAtivityoftheUntreated
and BioremediatedReiflyTarSite
Soil
Preliminary mutagenic evaluation of the
five RTS soils in the Spiral technique with
seven Salmonella strains clearly identified
strains YG1041 and YG1042, both with
and without S9, as the most responsive
test conditions (Table 1). Subsequently,
these two strains were used in the
Salmonella plate incorporation assay and
the mutagenic potencies (revertants per
microgam) from the Bernstein linear
regression model are shown in Table 2. A
summary of the RTS soil data for
YG1041 and YG1042 in the plate incor-
poration technique is available (57). The
mutagenic potencies for the BS in
YG1041 were >25-fold more mutagenic
than those ofthe UTS; the BP mutagenic
potencies were >3-fold more mutagenic
than the UTS in YG1041. The mutagenic
activity for the BS and BP extracts in
YG1042 was reduced when compared to
YG1041 but their mutagenic potencies
were considerably above those for the
UTS. The CMP, LT, and UTS muta-
genic potencies were moderate with
YG1041, +S9, but nonmutagenic without
S9 in both strains. There was not a
doubling of mutagenic potencies (in
YG1041, +S9) for the compost and land
treatment extracts compared to the UTS
extract; therefore, their mutagenic poten-
cies were not appreciably different from
the UTS mutagenic potencies (58). LRB,
the procedural solvent control, was not
mutagenic, as expected.
NitrowductseStudy
The strong mutagenic activity present in
the YG strains, especially without S9
addition, suggested that the BS extract
contained nitroarenes. To further investi-
gate this hypothesis, the BS extract was
tested for mutagenic activity in TA98 and
TA98NR (nitroreductase deficient) at five
Table 1. Mutagenic potencies (revertants per microgram) of Reilly Tar site soil extracts in the preliminary spiral
mutagenicity assay.a
Strain S9 BS BP CMP LT UTS lRB
YG1041 - 16.0 3.6 1.4 NM NM NM
+ 16.4 3.8 NM NM NM NM
YG1042 - 6.7 NM 1.4 NM NM NM
+ 4.3 2.2 NM NM NM NM
TA98 - NM NM 0.7 NM NM NM
+ 2.3 NM NM NM NM NM
TA100 - NM 1.3 1.1 NM 0.7 NM
+ NM 1.9 NM NM NM NM
TA97 - 0.6 NM NM NM NM NM
+ 0.8 NM NM NM NM NM
TA102 - 0.8 NM NM NM 1.0 NM
+ NM 1.4 NM 0.6 0.6 NM
TA104 - NM NM NM NM NM NM
+ NM NM NM NM NM NM
NM, not mutagenic. aMutagenic potencies from the Bernstein linear regression model (51). Mutagenic potencies
less than 0.5 and those thatwere nonsignificant are noted as NM.
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Table 2. Mutagenic potencies of the extracts from the
Reilly Tar site in the plate incorporation mutagenicity
assay.
Revertants/pg in two strainsa
YG1041 YG1042
Samples -S9 +S9 -S9 +S9
UTS NM 1.2 NM 0.17
LRB NM NM NM NM
BS 38.6b 31.4b 18.0b 8.9b
BP 3.0b 5.0b 1.3b 1.7b
CMP NM 2.3c NM 0.2
LT 0.16 1.8c NM 0.2
aMutagenic potencies were calculated from the linear
regression model of Bernstein (51). Values greater
than 0.1 were mutagenic. The rankings were as fol-
lows: values <0.1 were NM; values >0.1 to 1.0 were
weakly mutagenic; values 1.0 to 10.0 were moderately
mutagenic; values .10.0 were strongly mutagenic.
bMutagenic response, which was significantly different
from the UTS (>2-fold difference). BPvalues in YG1042
were significant because the values for UTS were not
mutagenic (-S9) and there was a 10-fold difference in
the +S9 comparison. cElevated mutagenic response
above UTS +S9 slope.
dose levels, triplicate plates per dose. If
mutagenic activity were reduced in
TA98NR, the presence of nitroarenes
would be further implicated. Mutagenic
activity was reduced by 50% in the BS
extract with strain TA98NR [i.e., at 1000
pg/plate, mutagenicity was reduced to
135 revertants in TA98NR from 267
revertants in TA98 (data not shown)].
These data supported the hypothesis that
the mutagenic activity in the BS was due
to nitroarenes.
ReproducibilityStudies
Table 3 contains the data for the
reproducibility evaluation of both the
bioassay and the extraction scheme. The
mean variation in the bioassay for each BP
extract over a 3-week period (horizontal
columns in Table 3) was 13.3%. The
mean variation in the extraction scheme
for the three BP extracts over a 3-week
period (vertical columns in Table 3) was
12.7%. These low variations confirmed
our confidence in the mutagenic potencies
and suggested that the mutagens in the BP
extract were stable at room temperature
for at least 3 weeks.
BioavailabilityStudy
The bioavailability of the mutagens in the
UTS and the BP extracts was investigated
by extracting these two soils with six dif-
ferent solvents and then testing these
extracts in YG1041 with and without S9
addition. Samples were tested at five dose
levels, and the 100 pg/plate data are
Table 3. Reproducibility of the Salmonella assay and the extraction scheme by analyses of three separate extrac-
tions ofthe biopile soil from the ReillyTar site.
Revertants/pga
Sample Assay 1 Assay 2 Assay 3 Assay CVb
Biopile 1 3.6 3.5 2.9 11.4
Biopile 2 3.0 2.7 2.2 15.2
Biopile 3 3.3 2.7 2.6 13.2
Extraction: scheme CVb 9.1 15.5 13.6
aMutagenic potencies from the linear regression Bernstein model, which rejects nonlinear points from the upper
portion of the dose-response curve (51). Three separate BP soil samples (1, 2, and 3) were extracted on the same
day. Assay parameters were as follows: Salmonella strain YG1041, 10 dose levels in the linear portion of the
dose-response curve (10-100 pg in 10 pg intervals), three plates/dose, no S9 addition, plate incorporation assay;
assays were conducted 1 week apartfrom each other. bSD/meanx 100%.
depicted graphically in Figure 1 (-S9) and
Figure 2 (+S9). The dotted lines on the
two graphs denote DMSO solvent control
values (100 revertants). An unambiguous
mutagenic response was considered to be
300 revertants or three times the solvent
control. Figure 1 demonstrated that for the
direct-acting conditions, the BP extract
had considerably more mutagenic activity
than the UTS, especially with the water
extract, which accounted for approximately
40% of the total mutagenicity in the BP
extract. The toluene and DCM extracts of
the BP soil without S9 also demonstrated
appreciable mutagenic activity (Figure 1).
When tested with S9 (Figure 2), the muta-
genicity in the water extract ofthe BP soil
was equal to the mutagenicity seen with
DCM extraction for the UTS and BP.
These data demonstrated that the muta-
gens in the BP soil were soluble in water,
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DCM, and toluene. Neither the saltwater
(artificial seawater) nor the 50:50 mix nor
the Corexit 9527 extracted significant
mutagenic activity from the BP soil
(Figures 1 and 2).
Discussion
MutagenicActivityinthe Reilly
TarSiteSoilExacts
The in vitro approach used for the geno-
toxic analyses of bioremediated soils in
this study contained three main parts: ini-
tial mutagenicity screening ofsoil extracts
in the Spiral technique; subsequent plate
incorporation assays to accurately deter-
mine mutagenic potencies (revertants per
microgram); and a bioavailability study
with a multiple solvent testing scheme.
The value of this approach was the Spiral
screening provided a rapid inexpensive
Biopile
~ Untreated soil
Corexit Water Saltwater 50:50 Toluene
Extract
DCM DMSO
Figure 1. Mutagenic activity in Salmonella strain YG1041 of untreated soil and biopile soil extracts (100 pg/plate)
from the Reilly Tar site tested without S9 and extracted with six different solvents.
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Figure 2. Mutagenic activity in Salmonella strain YG1041 of untreated soil and biopile soil extracts (100 pg/plate)
from the Reilly Tar site tested with S9 and extracted with six different solvents.
method to determine mutagenic activity;
the plate incorporation assay permitted
the determination of mutagenic potencies
that could be ranked; and the bioavail-
ability study identified the solubility of
the mutagens. Obviously, the test strains
and solvents could be modified to account
for varying environmental conditions
surrounding different types of hazardous
waste sites.
Ranking mutagenic activity is impor-
tant in environmental testing to identify
the most mutagenic samples and to priori-
tize multiple samples from the same site for
future testing. Bioavailability studies are
important for Superfund sites with both
marine and freshwater boundaries (e.g., a
marsh or a river that flows into the sea)
because mutagens in such a site may be
more soluble in either fresh water or seawa-
ter. Bioavailability could change depending
on the soil type, the specific environmental
conditions at the site, and the chemistry of
the toxicant. In addition, on-site bioreme-
diation could metabolize the mutagens
into more water-soluble chemicals, which
then could more easily contaminate
groundwater (Figures 1 and 2).
Fractionation and chemical analysis of
the RTS soils were conducted to identify
signature mutagens and are more fully dis-
cussed in Brooks et al. (43). When con-
ducting toxicologic evaluation ofhazardous
waste sites, chemistry alone is not adequate
to fully measure decreases or increases in
toxicity of the soil or water. Only by the
coupling ofchemical and biologic analyses
can a complete toxicologic evaluation be
made. For example, the mutagenic activity
ofthe BS sample in this research increased
significantly even though the priority PAH
concentrations were reduced 62% by
bioremediation (43).
The initial use of the Spiral technique
(42) permitted a large amount of muta-
genicity testing to be completed with a
minimal amount of supplies and effort
(Table 1). Each Spiral plate contained 11
dose levels over more than an order of
magnitude in range (e.g., 138-1760
pg/plate equivalents). In addition, the +S9
plates provided an S9 concentration range
from 100 to 8% of the S9 mix, which
gave a dose response for both S9 and sam-
ple concentrations. The major disadvan-
tage of the Spiral technique was that the
variation in this technique was large
(20-100% CV); therefore, the minimal
mutagenic potency for a positive muta-
genic result in the Spiral technique was
raised to 0.5 from 0.1 in the plate incor-
poration assay (Tables 1 and 2). The strat-
egy in this study was to test seven strains
initially: TA98 and TA100 (standard
Salmonella tester strains), YG1041 and
YG1042 (derived from TA98 and TA100,
respectively, that contain plasmids with
the metabolic activation enzymes nitrore-
ductase and acetyltransferase); TA102 and
TA104 (that detect oxidative aldehydes and
ketones such as formaldehyde); and TA97
(that detects unusual mutagens such as
9-aminoacridine, which distort DNA but
do not directly bind to DNA).
After the Spiral assay defined YG1041
and YG1042 as the most responsive strains,
the plate incorporation technique permitted
the generation of mutagenic potencies to
rank mutagenic activity (Table 2). The pro-
tocol for the plate assay (10 dose levels in
the linear portion of the dose-response
curve, triplicate plates per dose) reduced
variation in the Salmonella assay to 15% or
less (Table 3). When the CV remain below
25%, a doubling of mutagenic potency
becomes significant (58) and accurate rank-
ing of mutagenic activity can be accom-
plished (59,60). When other Salmonella
testing protocols are used (i.e., five dose lev-
els over several orders ofmagnitude for the
test sample), toxicity or saturation ofthe S9
metabolic activation system can cause the
variation in mutagenic potencies to exceed
100% (58).
In this research, the ability to accu-
rately measure and quantify mutagenic
activity of the four bioremediation
processes allowed their effectiveness to be
determined (Table 2). Elevated mutagenic
activity was detected in the BS and
BP extracts that was not present in the
UTS (Table 2). The high direct-acting
mutagenic activity in the BS extract was
surprising because creosote had been
mutagenic only with S9 addition (5).
One possible reason for this direct-acting
mutagenic activity may be that the BS
process contained activated sludge from a
municipal wastewater treatment facility
that had a high input from industrial
sources. The sludge may have contained
nitroarenes, which are direct-acting muta-
gens, are highly mutagenic (61), and have
been detected in sludge from wastewater
treatment plants from an industrial area
(62). Although unlikely, the BS process
may have allowed both anaerobic and/or
aerobic processes to generate nitrogen-
containing hydrocarbons. Nitroarenes
were indicated in the BS extract by muta-
genic activity in the YG strains without
S9 and by a 50% reduction of mutagenic
activity in TA98NR. However, because
the BS was not tested without sludge, we
cannot state if the increased mutagenic
activity was due to the added sludge or
the process itself. This will require further
testing. The BP sample did not contain
activated sludge; it contained 1% cow
manure, which could have contained trace
amounts of nitroarenes from the cows'
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diet. The BP sample also contained fungi
in addition to bacteria, which may have
changed the metabolism in the BP reac-
tor. The CMP also contained cow manure
but the corn cobs may have eliminated
the relatively small amount of direct-
acting mutagenic activity by absorption.
The LT did not contain any added
manure or fungi and had little mutagenic
activity. All possible modifications to any
one procedure were not investigated in
this research. However, the four bioreme-
diation procedures were calibrated by the
engineers to perform in an optimal manner.
The reductions in PAH concentrations
(48 to 74%) in this study (43) are in
agreement with a 50% reduction in cre-
osote (by weight) conducted by Chapman
and co-workers (63). The PAH reduc-
tions indicated that the four bioremedia-
tion processes were closely equivalent.
When the mutagenicity data were evalu-
ated along with the PAH data, CMP and
LT processes were the most efficient and
least toxic bioremediation procedures.
Reproducibilityand
BioavailabilityStudies
The reproducibility and low variation of
the extraction scheme and the bioassay
results were excellent (Table 3), which then
allowed a meaningful comparative investi-
gation into the bioavailability ofthe muta-
gens in the UTS and BP soil (Figures 1 and
2). The bioavailability results (Figures 1
and 2) agreed with the mutagenicity results
in Table 2. Mutagenic activity was detected
in the UTS with S9 and DCM; however,
water was able to extract both direct-acting
and indirect-acting mutagens from the BP
soil. The fact that the BP process made the
mutagens soluble in water may be signifi-
cant for on-site bioremediation, where
water-soluble mutagens could contaminate
groundwater supplies. Neither the saltwater
extraction nor the 50:50 mixture removed
any mutagens from the BP sample. The
addition ofa salt will generally change the
characteristics ofa solvent, including water.
Because oil spills and creosote waste sites
may have solvent fronts moving away from
the point source ofthe contamination that
may contain contaminants, the toluene
extract data in Figure 1 showed that such a
solvent front could contain solubilized
mutagenic components.
Bioremediation is a powerful tool that
can be used to lessen the mutagenic and car-
cinogenic hazards present at Superfund sites.
However, more research is needed on the
techniques ofbioremediation to increase its
efficiency. The coupling ofchemical and in
vitro biologic analyses can play a key role in
the evaluation and monitoring ofbioreme-
diation processes, as demonstrated by this
research (43).
DISCLAIMER: This manuscript has been
reviewed by the National Health and
Environmental Effects Research Laboratory,
U.S. EPA, and approved for publication.
Approval does not signify that the contents
necessarily reflect the views and policies of
the agency, nor does mention of trade
names or commercial products constitute
endorsement or recommendation for use.
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